NCT00138528View on ClinicalTrials.gov

Other Effects of Fluvastatin Are Investigated in Patients With Metabolic Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions
Metabolic Syndrome
Interventions
DRUG

Fluvastatin

Trial Locations (1)

Unknown

Novartis, Nuremberg

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00138528 - Other Effects of Fluvastatin Are Investigated in Patients With Metabolic Syndrome | Biotech Hunter | Biotech Hunter